Embelin Promotes Oncolytic Vaccinia Virus-Mediated Antitumor Immunity Through Disruption of IL-6/STAT3 Signaling in Lymphoma.
Peng WangYi WuChen YangGuanan ZhaoYonghua LiuGang ChengShibing WangPublished in: OncoTargets and therapy (2020)
Our findings indicate the utility of embelin as an adjuvant for oncolytic viro-immunotherapy.